COMP <GO>
IMA vs EXOZ // EV/EBITDA & P/E VALUATION
ImageneBio Inc. (NASDAQ) VS. eXoZymes Inc. (NASDAQ) • 15-METRIC TALLY: IMA 2
— EXOZ 1
■ METRIC PARITY
LAST: $4.05 (-3.57%) • MKT CAP: $46.0M
valuation
—
LAST: $4.11 (-2.72%) • MKT CAP: $38.2M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMA VS. EXOZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMA | EXOZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -17.45% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | EXOZ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.3 | 36.2 | +4.02 | IMA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.0M | $38.2M | $7.7M | IMA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMA REV | EXOZ REV | IMA GROSS % | EXOZ GROSS % | IMA FCF | EXOZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $800.0K | $0 | — | — | -$47.8M | -$6.7M |
| FY 2024 | $3.5M | $0 | — | — | -$21.3M | -$8.9M |
| FY 2023 | $9.2M | $70.1K | — | — | -$79.7M | -$1.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMA // BETA —
EXOZ // BETA —